About Cyclopharm
Cyclopharm is a company based in Sydney (Australia) founded in 1986. The company has 95 employees as of December 31, 2024. Cyclopharm offers products and services including Technegas. Cyclopharm operates in a competitive market with competitors including Body Vision Medical, Perfint Healthcare, Positrigo, Polarean Imaging and Mobius Imaging, among others.
- Headquarter Sydney, Australia
- Employees 95 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cyclopharm Limited
-
Annual Revenue
$17.08 M (USD)4.68as on Dec 31, 2024
-
Net Profit
-$8.18 M (USD)-180.75as on Dec 31, 2024
-
EBITDA
-$8.08 M (USD)-43.61as on Dec 31, 2024
-
Latest Funding Round
$9.81 M (USD), Post-IPO
Feb 04, 2026
-
Investors
Not available
-
Employee Count
95
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cyclopharm
Cyclopharm is a publicly listed company on the ASX with ticker symbol CYC in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cyclopharm
Cyclopharm offers a comprehensive portfolio of products and services, including Technegas.
Technology for pulmonary diagnostic imaging and patient management.
Funding Insights of Cyclopharm
Investments & Acquisitions by Cyclopharm
Investment portfolio details for Cyclopharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cyclopharm
Detailed financials for Cyclopharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cyclopharm Comparisons
Peer comparison for Cyclopharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cyclopharm
Cyclopharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Body Vision Medical, Perfint Healthcare, Positrigo, Polarean Imaging and Mobius Imaging, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Image-based intra-body navigation technology for medical diagnostics is developed.
|
|
| Locked | Locked | Locked |
Solutions for image-guided interventional procedures are developed.
|
|
| Locked | Locked | Locked |
A compact brain PET scanner for dementia monitoring is offered.
|
|
| Locked | Locked | Locked |
Noble gas polarizers for hyperpolarized pulmonary MRI are developed.
|
|
| Locked | Locked | Locked |
Developer of a CT medical imaging system
|
|
| Locked | Locked | Locked |
Portable CT scanners are developed and marketed for medical use.
|
Detailed competitors of Cyclopharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cyclopharm
Complete news archive for Cyclopharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cyclopharm
Cyclopharm was founded in 1986 and raised its 1st funding round 40 years after it was founded.
Cyclopharm is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
James McBrayer is the current CEO of Cyclopharm.
As of Dec 31, 2024, the latest employee count at Cyclopharm is 95.
Annual revenue of Cyclopharm is $17.08M as on Dec 31, 2024.
Cyclopharm was founded in 1986 in Sydney, Australia, and operates in the healthcare sector focused on diagnostic imaging. Radiopharmaceuticals and medical devices are developed by the company, including TECHNEGAS, a radiolabelled carbon substance produced from Technetium-99m. This gaseous agent is inhaled by patients and detected via nuclear medicine tomography to visualize lung alveolar spaces. Operations center on advancing lung diagnostic technologies for clinical use.
Cyclopharm's top competitors include Positrigo, Polarean Imaging and Neurologica.
Cyclopharm offers Technegas.
Yes, Cyclopharm is publicly traded on ASX under the ticker symbol CYC.
The ticker symbol of Cyclopharm is CYC on ASX.